Kolltan Pharmaceuticals Inc Receives $35,000,000 Series A Financing

  • Feed Type
  • Date
    1/9/2009
  • Company Name
    Kolltan Pharmaceuticals Inc
  • Mailing Address
    50 Rock Hill Road Woodbridge, CT 06525
  • Company Description
    Kolltan is a development-stage company advancing therapeutics that target well-defined and validated molecular mechanisms of disease in areas of critical clinical need.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The proceeds of the Series A financing will be used to advance Kolltan’s therapeutic development pipeline.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy